How much funding has QuantX Biosciences raised?

QuantX Biosciences has raised $130.0M in total funding, most recently a series a round.

Who are QuantX Biosciences's investors?

QuantX Biosciences's investors include OrbiMed, Lilly Asia Ventures, Sanofi Ventures, Creacion Ventures, Hongshan Capital Group.

When was QuantX Biosciences founded?

QuantX Biosciences was founded in 2022.

Where is QuantX Biosciences headquartered?

QuantX Biosciences is headquartered in Princeton, New Jersey, United States.

What industry is QuantX Biosciences in?

QuantX Biosciences operates in Biotech.

How many employees does QuantX Biosciences have?

QuantX Biosciences has 11-50 employees.

QuantX Biosciences

QuantX - Transforming the discovery of oral small molecule therapeutics

Princeton, United States · Founded 2022 · $130.0M raised

Biotech

Headquarters: Princeton, New Jersey
Employees: 11–50
Founded: 2022
Business Model: B2B

Website: quantxbio.com
Total Funding: $130.0M
Last Round: $45.0M Series AFeb 2026
Rounds: 2

About

QuantX Biosciences is a Princeton, New Jersey-based biotechnology company founded in 2022 that uses proprietary computational modeling to accelerate the discovery of oral small molecule therapeutics. The company focuses on immunology and inflammation targets, advancing a pipeline of oral small molecule inhibitors against clinically validated pathways. Co-founded by CTO Yax Sun and CSO Wayne Tang, QuantX raised $85M in an oversubscribed Series B in 2026.

Summary

QuantX Biosciences is a Biotech company based in Princeton, United States, founded in 2022. It has raised $130.0M in total across 2 rounds, most recently a $45.0M Series A round in Feb 2026. Investors include OrbiMed, Lilly Asia Ventures and Sanofi Ventures.